IMCC
IMCC
NASDAQ · Pharmaceuticals

Im Cannabis Corp

$0.16
-0.01 (-7.09%)
As of Jun 23, 10:14 PM ET ·
Financial Highlights (FY 2026)
Revenue
287.57M
Net Income
-56,336,631
Gross Margin
15.6%
Profit Margin
-19.6%
Rev Growth
+16.6%
D/E Ratio
3.44
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 15.6% 15.6% 43.8% 43.8%
Operating Margin -18.9% -17.0% 16.8% 17.0%
Profit Margin -19.6% -18.6% 13.3% 12.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 287.57M 246.54M 4.60M 5.55M
Gross Profit 44.98M 38.56M 2.01M 2.43M
Operating Income -54,464,978 -42,025,445 771.4K 945.4K
Net Income -56,336,631 -43,469,622 612.3K 695.3K
Gross Margin 15.6% 15.6% 43.8% 43.8%
Operating Margin -18.9% -17.0% 16.8% 17.0%
Profit Margin -19.6% -18.6% 13.3% 12.5%
Rev Growth +16.6% +16.6% +11.5% +14.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 876.9K 876.9K 7.39M 5.68M
Total Equity 255.3K 255.3K 8.30M 9.81M
D/E Ratio 3.44 3.44 0.89 0.58
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -50,172,585 -40,864,159 960.1K 1.02M
Free Cash Flow 405.9K 317.4K